Title: Comparative Study of Buccal Midazolam and I.V Diazepam for Acute Treatment of Seizure in Pediatrics Age Group
Authors: Rakesh Ranjan Kumar, Rizwan Ahmar
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.205
Abstract
Background: Seizure episode is a common pediatrics neurological emergency requiring hospitalization. Urgent treatment of seizure results in favorable prognosis. Buccal Midazolam can be better drugs than intravenous (I/V) diazepam as first choice in situation where there is difficulty in accessing the i. v line urgently or in remote area where availability of trained person to control seizure is limited.
Materials and Methods: Total 50 (29 boys, 21 girls) patients were enrolled in the study. In the study group A, patients received buccal Midazolam (0.3 mg/kg/ dose) and in control group B, patient received I.V Diazepam (0.2 mg/kg/dose).
Results: In 24 cases (96%) of both group A and B, seizures were aborted by giving buccal Midazolam and i.v Diazepam respectively (P > 0.05). The mean time needed for cessation of seizures in group A was 90 ± 150 seconds (1.68 min) with the lowest time being 32 seconds and highest being 289 seconds while it was 80 ± 130 seconds (1.4 minutes) in group B with the lowest being 31 seconds and the highest being 299 seconds. The difference in time taken to control seizures between two groups was statistically insignificant (P = 0.641). No significant side effects were seen in either group.
Conclusions: Buccal Midazolam is quite safe drugs, equally effective than I.V Diazepam in controlling the prolonged seizure in children and can be given easily.
Keywords: prolonged seizure, Buccal Midazolam, i.v Diazepam, Efficacy.
References
1. Chin RF, Neville BG, Peckham C, Wade A, et al. Treatment of community-onset, childhood convulsive status epileptics: A prospective, population-based study. Lancet Neurol 2008; 7: 696-703.
2. Scantlebury MH, Heida JG, Hasson HJ, Velísková J, et al. Age-dependent consequences of status epilepticus: Animal models. Epilepsia 2007; 48: 75-82.
3. Anderson M. Benzodiazepines for prolonged seizures. Arch Dis Child Educ Pract Ed 2010; 95: 183-9.
4. Schwagmeier R, Alincic S, Striebel HW. Midazolam pharmacokinetics following intravenous and buccal administration. Br J Clin Pharmacol 1998; 46: 203-6.
5. Talukdar B, Chakrabarty B. Efficacy of buccal Midazolam compared to intrav-enous diazepam in controlling convulsions in children: A randomized controlled trial. Brain Dev 2009; 31: 744-9.
6. Kutlu NO, Dogrul M, Yakinci C, Soylu H. Buccal Midazolam for treatment of prolonged seizures in children. Brain Dev 2003; 25: 275-8.
7. Tonekaboni SH, Shamsabadi FM, Anvari SS, Mazrooei A, et al . A comparison of buccal Midazolam and intravenous diaze-pam for the acute treatment of seizures in children. Iran J Pediatr 2012; 22:303-8.
8. Muchohi SN, Kokwaro GO, Ogutu BR, Edwards G, et al Pharmacokinetics and clinical efficacy of Midazolam in children with severe malaria and convulsions. Br J Clin Pharmacol 2008;66: 529-38.
9. Melendez R, Batista D, Font D, Bausà T, et al. Prolonged convulsions treated with buccal Midazolam in a setting of mentally retarded patients with refractory epilepsy. Neurologia 2006;21: 411-3.